EP228-茶水間閒聊,FDA監管在業界眼中的盲點與挑戰 episode artwork

EPISODE · Sep 14, 2025 · 51 MIN

EP228-茶水間閒聊,FDA監管在業界眼中的盲點與挑戰

from 生醫人生旅歷 · host BioMeder

這集延續了第148集對FDA成立背景的討論,更深入探討FDA多年監管後出現的一些值得深思的問題。 本集內容來自個人和業界經驗分享,提出現象供大家思考,不是評斷對錯。 你可以聽到: 1. 減肥藥「猛建樂」(Mounjaro)與美國的複合藥局(compounding pharmacies)現象 2. FDA法規對創新的潛在阻礙 3. FDA使用者付費制度(如PDUFA)的利益衝突疑慮 4. FDA官員的「旋轉門條款」效應 本集內容提到的BMJ文章: https://bmjgroup.com/fda-staff-leaving-for-industry-jobs-given-behind-the-scenes-lobbying-advice/ 留言告訴我你對這一集的想法: https://open.firstory.me/user/ckssiau1vq5ic082295g8on9d/comments ✎ 留言: podcast.biomeder.com/contact-us 📧 Email: [email protected] 《生醫人生旅歷》podcast.biomeder.com   《BioMeder生醫人網摘》biomeder.com Powered by Firstory Hosting

Episode metadata supplied by the publisher feed · Published Sep 14, 2025

Embed this episode

Ready to play

EP228-茶水間閒聊,FDA監管在業界眼中的盲點與挑戰

0:00 51:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 生醫人生旅歷?

This episode is 51 minutes long.

When was this 生醫人生旅歷 episode published?

This episode was published on September 14, 2025.

Can I download this 生醫人生旅歷 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!